Oritain hits half a billion, but faces Companies Office scrutiny

Oritain hits half a billion, but faces Companies Office scrutiny
Grant Cochrane and director John Key discuss counterfeiting issues. (Image: Oritain)
Brent Melville
Dunedin company Oritain, which specialises in origin tracing and is valued at $558 million, may have to disclose its earnings.Last week, the biotech firm completed a US$57m (NZ$90m) raise, in a series C round led by London venture capital firm Highland Europe, which valued it at just over half a billion dollars.But while its foundation is about traceability, the firm's earnings remain opaque. It doesn’t report its financials in NZ, despite "officially" being overseas owned from December 2021. Under the Companies Ac...

More Finance

Investor visas a gold mine for private credit
Finance

Investor visas a gold mine for private credit

More than $55m committed for residency destined for credit funds which lend to NZ firms.

Aussie broker giant CBN enters NZ with Folio deal
Finance

Aussie broker giant CBN enters NZ with Folio deal

CBN is backed by ASX-listed Steadfast Group.

John Anthony 11 Aug 2025
Capital gains tax to solve house-price affordability crisis?
Finance

Capital gains tax to solve house-price affordability crisis?

ANZ's Richard Yetsenga said house-price affordability is a significant challenge. 

Staff reporters 07 Aug 2025
Surcharge ban may not be a win for consumers
Finance

Peter Griffin: Surcharge ban may not be a win for consumers

There are winners and losers in the surcharge move.

Peter Griffin 30 Jul 2025